AMSTERDAM (Reuters) – Akzo Nobel has agreed to sell its specialty chemicals business to investors led by U.S. private equity firm Carlyle Group for 10.1 billion euros ($12.6 billion), including debt — a milestone for the Dutch company as it struggles to recover from a tempestuous 2017.